Shandong Lukang Pharmaceutical Co (SHSE:600789) EBIT per Share : ¥0.55 (TTM As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Lukang Pharmaceutical Co EBIT per Share?

Shandong Lukang Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2025 was ¥0.12. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.55.

During the past 12 months, the average EBIT per Share Growth Rate of Shandong Lukang Pharmaceutical Co was -0.40% per year. During the past 3 years, the average EBIT per Share Growth Rate was 20.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 18.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Shandong Lukang Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SHSE:600789' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -54.4 Med: 17.9 Max: 91.3
Current: 20.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Shandong Lukang Pharmaceutical Co was 91.30% per year. The lowest was -54.40% per year. And the median was 17.90% per year.

SHSE:600789's 3-Year EBIT Growth Rate is ranked better than
67.39% of 825 companies
in the Drug Manufacturers industry
Industry Median: 8.3 vs SHSE:600789: 20.10

Shandong Lukang Pharmaceutical Co's EBIT for the three months ended in Mar. 2025 was ¥103 Mil.

Shandong Lukang Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Shandong Lukang Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Lukang Pharmaceutical Co EBIT per Share Chart

Shandong Lukang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

0.36

0.20

0.27

0.40

0.57

Shandong Lukang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EBIT per Share	Get a 7-Day Free Trial															0.12	0.26	0.09	0.09	0.12

Shandong Lukang Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Shandong Lukang Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	509.281	/	896.854
=	0.57

Shandong Lukang Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

	EBIT per Share		(Q: Mar. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	102.543	/	873.307
=	0.12

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.55

Shandong Lukang Pharmaceutical Co (SHSE:600789) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Shandong Lukang Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Shandong Lukang Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Lukang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Lukang Pharmaceutical Co Ltd (SHSE:600789) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 152 Taibai West Road, Jining, Shandong, CHN, 272021

Website

http://www.lkpc.com

Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.

Executives

Zhao Wei	Director
Peng Xin	Director
Dong Kun	Director
He De Feng	senior management
Gao Xiang You	Director
Cheng Jun	Director

Shandong Lukang Pharmaceutical Co Headlines

No Headlines